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Research Article 
INTRODUCTION 
Ethnomedicinal plants remain largely unexplored and 
there is a good scope for researchers and food proces-
sors to bring out these economical, easily grown plants 
to the mainstream food basket (Pala et al., 2019., 
Salmerón-ManzanoEsther et al., 2020).   Chenopodium 
album Linn, is one such plant with good nutritive value 
(fibre, fatty acids and minerals).  In India, it is called as 
Bathua and it belongs to Amaranthaceae family and 
Chenopodium genus (Bajwa Ali et al., 2019).  C. Album 
is rich in flavonoids that play an important role in its 
pharmacological and therapeutic properties.   
Flavonoids are phenolic compounds possessing a wide 
spectrum of biological activities and are studied for anti-
cancer and reducing the risk of cardiovascular diseases 
caused by oxidative stress (AlexanderVictor et al., 
2016, Thilakavathy Thangasamy et al., 2009).  C.Album 
has been found to possess the bioflavonoids, Quercetin 
and Kaempferol derivatives (Gohar and Elmazar 1997, 
Cutillo et al., 2006, Laghari et al.,2011) Hypercholester-
olemia is considered as one of the factors for coronary 
heart diseases.  Chemically synthesised drugs used to 
treat hypercholesterolemia contain statin group that on 
prolonged use causes muscle weakness, memory loss 
and inhibits coenzyme Q10 important for electron 
transfer in mitochondria (Wagstaff et al., 2003, Ja-
molowicz AI et al., 2015).  In this context, it is highly 
relevant to focus on plant derived flavonoids that are 
effective in treating hypercholesterolemia. 
Lanosterol synthase, also known as lanosterol cyclase, 
is a microsomal enzyme and a target for drugs lowering 
cholesterol (Telford et al., 2005, Vanessa et al., 2018).  
The potential anti-cholesteremic drug binds to the ac-
tive sites of the Lanosterol synthase enzyme and inhib-
its it.  To establish a plant derived flavonoid as a poten-
tial bioactive compound, it is important that we screen it 
theoretically and know its pharmacological and binding 
properties.    
In the present work, we carried out in-silico calculation 
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of bioactivity scores and drug like nature of the selected 
compounds from C.album  through Molinspiration 
(www.molinspiration.com ) (Khan et al., 2017).  In this 
calculation, it is observed that the selected molecules 
did not obey the Lipinski’s rule of 5 (Lipinski., 2004).  
However, biological activity spectrum of the compounds 
using PASS tool (Prediction of Activity Spectra for Sub-
stances) exhibits anti-cholesteremic activity.  Structure 
based docking approach is used to search for new drug 
targets assisting the process of new drug discovery.   
To evaluate the binding of these compounds with 
Lanosterol synthase enzyme, a grid-based docking 
method, Dockthor is used (Santos et al., 2020).   The 
present study aimed to calculate bioactivity spectrum of 
selected flavonoids present in C. album and their bind-
ing affinity towards Lanosterol synthase enzyme to act 
as a potential candidate for lowering cholesterol.   
MATERIALS AND METHODS 
Experimental 





10485148), rutin (CID5280805); quercetin-3-O-β-d-
glucopyranoside (Iso quercetin)  (CID 5280804); and 
kaempferol-3-O-β-d-glucopyranoside (Astragalin) (CID 
5282102) were obtained from pubchem.  Similarly, 
Lanosterol synthase (1W6J) was taken from Protein 
Data Bank (PDB) and these structures were used for in-
silico analysis.     
In Molinspiration, the bioactivity score of a molecule 
were calculated by its interaction with GPCR ligand, ion 
channel modulator, nuclear receptor ligand, kinase, 
protease and enzyme inhibitors then comparing it with a 
standard drug.  If the bioactivity score is greater than 
zero, then it is active, moderately active if the bioactivity 
score lies between -5.0 and 0.0 and inactive if less than 
5.0.  Drug likeness of the compounds was calculated 
using Lipinski’s rule of 5 (Lipinski., 2004).   
The key feature of PASS tool is to predict the biological 
activity spectrum of the compounds based on its chemi-
cal structure.  Biological activity of a compound is con-
sidered as an intrinsic property and in PASS it is de-
scribed by descriptors called Multilevel Neighborhoods 
of Atoms (MNA) (Filimonov et al., 1999).  Structural 
information of the molecule was processed as MNA 
descriptors that are generated in the program and 
based on the training set, Pa (probability of the com-
pound to be active) and Pi (probability of the compound 
to be inactive) were generated for each biological activ-
ity.  The values of Pa and Pi varied between 0.000 to 
1.000 and Pa+Pi <1. Though the compounds with 
Pa>0.8 were promising, they can match to an already 
existing chemical entity.  So, there is a probability of 
finding New Chemical Entities (NCE) for the com-
pounds with the activity range, 0.5<Pa<0.7 (Khan et al., 
2017).  However, in the present work, we were looking 
for the potential anti-cholesteremic activity of the com-
pounds.  
Dockthor program is developed by GMMSB/LNCC 
group and it uses MMFF94S force field as scoring func-
tion (Guedes et al., 2021).  It can easily dock highly 
flexible compounds with up to 40 rotatable bonds 
(Santos et al., 2020).  The grid center was chosen as 
40 and grid center was assigned for each ligand.  Bind-
ing affinity, total energy was calculated to predict the 
compound’s affinity in binding with lanosterol synthase.       
RESULTS AND DISCUSSION 
In the recent past, there is a growing demand for natu-
rally occurring antioxidants that play a role in inhibiting 
reactive oxygen species within the tissues and free 
radicals (Garnatje et al., 2017, Guarise et al., 2019).  
Polyphenols are such compounds that are present in 
plants exhibiting some important pharmacological prop-
erties. Polyphenols exhibit antioxidant property by 
scavenging free radicals, chelate with metal ions, inhibit 
oxidases, terminate free radical reactions (Vanessa et 
al., 2018).  C. Album is rich in polyphenols (Table 1) 
and has potential to serve as natural antioxidants.   
Pharmacological activity of a compound depends on 
the binding affinity towards the biological or drug target.  
The most common targets are enzymes, ion channel 
modulators, receptors etc.  In this study, the bioactivity 
S. No   Compound 













1 CID 11498684 -1.02 -2.09 -1.53 -1.68 -0.72 -1.15 
2  CID 10485148 -0.88 -1.89 -1.35 -1.42 -0.59 -0.99 
3  CID 5280805 -0.05 -0.52 -0.14 -0.23 -0.07 0.12 
4  CID 5280804 0.05 -0.04 0.13 0.19 -0.05 0.41 
5  CID 5282102 -0.05 0.10 0.10 0.20 -0.05 0.41 
Table 1. Bioactivity score of selected compounds of C. album. 
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score was calculated by binding to G protein-coupled 
receptor (GPCR), ion channel modulator, nuclear re-
ceptor and kinase, protease, enzyme inhibitors.  From 
table 1, it was observed that the values were in the 
range 0.0 and -5.0 suggesting moderate bioactivity for 
the selected compounds of the C.album.  This indicated 
that the selected compounds possessed properties that 
may be explored for potential drug activity. 
Lipinski’s rule of 5, screens out the molecules based on 
molecular weight, partition coefficient (log P), TPSA 
(Topological polar surface area), number of rotatable 
bond and number of hydrogen bond donors and accep-
tors.  Small molecules generally may be screened us-
ing this rule, but with increasing demand for plant de-
rived drug molecules that are generally large, it is diffi-
cult to comply with the rule but can still be biologically 
active.  It is observed that, there are many FDA ap-
proved biological molecules that do not obey Lipinski’s 
rule of 5 (Zhang MQ et al., 2007).  Table 2 depicts the 
scores of the compounds for Lipinski’s rule of 5.  From 
the table, it may be observed that, only two com-
pounds, CID 5280804 and CID 5282102 had molecular 
weight less than 500 and also number of rotatable 
bonds less than 5.  It may be observed that, the parti-
tion coefficient value is less than 5 for all the com-
pounds, suggesting good membrane permeability.  But 
the number of Hydrogen bond acceptors and donors 
are not in the range of Lipinski’s rule of 5.   
These compounds can be biological antioxidants that 
can scavenge free radicals and decrease the oxidative 
stress damage caused to the body and hence they can 
be used as dietary antioxidants. Further continuing the 
study, the biological activity spectrum of the com-
pounds was studied using ‘PASS’ to know whether the 
compounds have the potential to be pharmacologically 
active or not.  Biological activities like free radical scav-
enging, antioxidants, lipid peroxidase and kinase inhibi-
tors influence hypercholesterolemia (Charles-
Schoeman et al., 2015, Lee et al.,2014).  Hence, from 
the biological spectrum of the compounds, the Pa and 







TPSA (Å2) Topological 





Number of  
rotatable bonds 
1. CID 11498684 756.7 -1.76 328.35 20 12 8 
2. CID 10485148 740.7 -1.35 308.12 19 11 8 
3. CID5280805 610.5 -1.06 269.43 16 10 6 
4. CID 5280804 463.4 -2.96 213.33 12 7 4 
5. CID 5282102 448.4 0.12 190.28 11 7 4 
Compound 
Biological activity 
Free radical  
scavenger 
Lipid peroxidase  
inhibitor 
Antioxidant Kinase inhibitor 
Pa Pi Pa Pi Pa Pi Pa Pi 
CID 11498684 0.992 0.001 0.989 0.001 0.934 0.002 0.801 0.006 
CID 10485148 0.982 0.001 0.966 0.002 0.897 0.003 0.784 0.007 
CID 5280805 0.988 0.001 0.987 0.001 0.923 0.003 0.819 0.005 
CID 5280804 0.978 0.001 0.980 0.001 0.910 0.003 0.804 0.005 
CID 5282102 0.969 0.001 0.960 0.002 0.907 0.003 0.837 0.004 
Table 3. Pa and Pi values from the biological spectrum of C. album. 
Fig. 1.  Molecular docking of the compounds with Lanosterol synthase. 
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Pi values of the mentioned biological activities are 
listed for the compounds present in C.album in Table3.  
Activity of the compound is predicted based on the 
Bayesian approach, where the structure of the com-
pound is compared with that of the existing active sub-
strate in the database. Leave-one-out cross-validation 
(LOO CV) estimates the accuracy of the method to be 
95% (Filimonov et al., 1999).  From the table, it is clear 
that the probability of the compounds to be biologically 
active for the particular activity was ranging from 0.784 
to 0.992, suggesting that these compounds are effec-
tive for treating hypercholesterolemia.               
Molecular docking studies with lanosterol synthase and 
the compounds of C.album using dockthor gave infor-
mation about the binding affinity, most stable structure 
and binding mode.  According to the present docking 
studies, the binding affinity for all the molecules is in 
the same range, but for kaempferol-3-O-(2′′,6′′-di-O-α-l
-rhamnopyranosyl)-β-d-glucopyranoside, the other pa-
rameters like total energy, Vander Waals energy is also 
promising, as seen in Table 4.  The present study ob-
served that all the ligands bind with lanosterol syn-
thase, as shown in Fig.1.  This clearly indicates that 
these compounds have the potential to serve as dietary 
antioxidants.  The present study observed that all the 
ligands bind with lanosterol synthase.  Further studies 
may be taken up to establish these plant - derived com-
pounds as an alternative to statin group in treating hy-
percholesterolemia.      
Conclusion  
The present study observed that compounds in 
C.album have the potential to be used as an alternative 
to the statin group of compounds in treating cholesterol.  
Even though, the compounds do not obey Lipinski’s 
rule of 5, they have potential biological activity as ob-
served in the biological spectrum of the compound. 
This is also evident from Pa, Pi values and as well as 
docking studies.  C.album has a nutritive and therapeu-
tic value that may be exploited to impart nutrition and 
prepare functional foods.  With many biologically active 
constituents present in it, they may be isolated and fur-
ther studies may be taken up for the development of 
drugs.  With increasing societal awareness towards 
health and with emerging new technologies like syn-
thetic biology, there will be demand for plant derived 
drug molecules and their derivatives in treating, espe-
cially lifestyle disorders.   
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